Metycor

Metyrapone, the active ingredient in Metycor, is a 11-beta-hydroxylase inhibitor presented as a tablet for oral use. It is employed in the diagnostic testing of adrenal insufficiency and in the treatment of Cushing's syndrome in adult patients.\n\nGNH India supplies Metycor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metycor acts on adrenal steroidogenesis and is used for conditions that require modulation of cortisol production.\n\nDiagnostic testing of adrenal insufficiency: helps assess the capacity of the adrenal glands to produce cortisol.\nCushing's syndrome: reduces excess cortisol synthesis to control hypercortisolism.\nResearch investigations: used as a tool to study adrenal function and steroid biosynthesis pathways.

Metycor may cause a range of adverse reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Nausea\n- Fatigue\n- Dizziness\n- Headache\n- Abdominal discomfort\n- Transient hypoglycemia\n\nSerious or Rare Side Effects:\n- Acute adrenal insufficiency\n- Severe hypotension\n- Allergic reactions (rash, angioedema)\n- Hepatic dysfunction\n- Hyponatremia\n- Severe hypokalemia

Before initiating therapy, clinicians should consider several safety factors.\n\nPregnancy: safety unknown; use only if benefit outweighs risk.\nBreastfeeding: unknown excretion; avoid unless essential.\nRenal impairment: dose adjustment may be required; monitor renal function.\nHepatic impairment: monitor liver enzymes regularly.\nConcomitant glucocorticoids: may mask signs of adrenal insufficiency.\nStore at room temperature: keep in the original container, protect from moisture and light.

Metycor can interact with other medicines that affect steroid metabolism or cardiovascular status.\n\nMajor Interactions (Avoid):\n- Ketoconazole: additive inhibition of cortisol synthesis may cause severe adrenal suppression.\n- Strong CYP11B1 inducers (e.g., rifampin): reduce Metyrapone efficacy.\n- High‑dose glucocorticoid replacement: may mask adrenal insufficiency symptoms.\n\nModerate Interactions (Monitor Closely):\n- Antihypertensive agents: may enhance hypotensive effects.\n- Oral hypoglycemics or insulin: increased risk of hypoglycemia.\n- Diuretics: may exacerbate electrolyte disturbances.